Barclays Downgrades Doximity to Equal-Weight, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Negative 85.9%

Neg 85.9% Neu 0% Pos 0%

Barclays analyst Glen Santangelo downgrades Doximity (NYSE:DOCS) from Overweight to Equal-Weight and lowers the price target from $38 to $20.